StemGrow® Stem Cell Therapy for Hair Loss
Regenerative Medicine for Hair Loss and Alopecia
UC-MSC-derived exosome therapy is an emerging, physician-supervised approach to regenerative medicine for hair loss and alopecia. StemGrow® is a stem cell treatment for hair loss, a non-surgical hair loss treatment and alternative to hair transplant surgery for patients who still have existing hair and active follicles.
Targeting the Underlying Causes of Hair Loss and Alopecia
UC-MSC-derived exosomes are delivered directly to the scalp to support hair follicle activity, targeting the biological factors behind hair loss.
The goal is to calm localized inflammation and create a signaling environment that favors follicle recovery. Results vary and are evaluated during your medical consultation.
Growth Factors
Inflammation Modulation
Follicle Support
How StemGrow® Compares to Other Hair Loss Options
| Option | Approach | Best suited for | Downtime |
|---|---|---|---|
| Hair transplant surgery | Surgical relocation of existing follicles | Advanced, patterned baldness | Days to weeks |
| Low level laser therapy (LLLT) | Light therapy intended to stimulate existing follicles | Very early, mild thinning | None |
| StemGrow® exosome therapy | UC-MSC-derived exosomes delivered to scalp tissue | Patients with existing hair and active follicles seeking a non-surgical option | Minimal |
| Topical and oral medication | Ongoing pharmaceutical management | Maintenance, mild cases | None |
Unlike surgical options, exosome therapy doesn’t relocate follicles, it works with the follicles you already have. That’s why candidacy depends on the condition of your existing hair: patients with fully dormant or absent follicles usually aren’t good candidates, while those in earlier stages of thinning are more likely to see a response. A physician checks your scalp and follicle status during intake to determine whether stem cells alopecia protocols are right for you.
For patients who have researched light therapy or LLLT devices without meaningful results, exosome delivery works through a different mechanism, targeting the inflammatory and signaling environment at the follicle rather than only stimulating blood flow.
Harnessing the Potential of UC-MSC Derived Exosomes



Regenerative Medicine for Hair Restoration
UC-MSCs
UC-MSC Derived Exosomes
Scalp Delivery and Follicle Targeting
Inflammation and Microenvironment Modulation
Cellular Signaling and Tissue Support
Why Patients Travel for Stem Cell Hair Restoration
Research on UC-MSC-derived exosomes and their role in hair follicle biology is still developing, but it offers a scientifically grounded option for people affected by hair loss and alopecia. The goal is to create conditions that favor follicle recovery — outcomes are assessed patient by patient.
Frequently Asked Questions
How does the therapy work for hair loss?
UC-MSC derived exosomes are tiny vesicles — approximately 1000 times smaller than the stem cells from which they originate. Think of them as specialized messengers packed with bioactive molecules that facilitate cellular communication and healing. While UC-MSCs provide direct tissue repair through cell differentiation, exosomes deliver targeted anti-inflammatory and regenerative signals to damaged hair follicles. These nano-sized vesicles are particularly effective because they can penetrate deeper into tissues and carry potent healing information without the need for cell proliferation, making them ideal for addressing the underlying biological mechanisms that contribute to hair loss.
How does the treatment process work?
The treatment involves the precise administration of UC-MSC derived exosomes into the affected areas of your scalp. This targeted delivery system ensures that the regenerative signals reach the hair follicles directly. During the procedure, our medical team uses specialized techniques to deposit these healing exosomes into areas experiencing hair loss. The exosomes immediately begin working to stimulate cellular communication, reduce inflammation, and promote the natural hair regrowth process. Most patients notice initial improvements within a few months, with continued enhancement over time as the follicles respond to the regenerative signals.
Is the treatment safe, and what side effects might occur?
The use of umbilical cord mesenchymal stem cells and their derived exosomes is considered very safe due to their ethical sourcing and low immunogenicity. Since UC-MSCs are derived non-invasively from postnatal tissue, there are no ethical concerns, and the risk of immune rejection is minimal. The exosomes, being natural cellular products, integrate seamlessly with your body's healing processes. Side effects are typically minimal and may include temporary mild swelling or redness at the injection sites, which resolves quickly. Our medical team conducts thorough evaluations to ensure you're a good candidate for treatment.
How long before I see results, and are they permanent?
Most patients begin to notice visible improvements in hair density and quality within 2–3 months after treatment, with continued gains over the following months as follicles progress through the growth cycle. Results vary depending on the extent of hair loss, overall health, and adherence to the recommended treatment plan. While regenerative therapies can produce long-lasting benefits, ongoing maintenance sessions may be advised to sustain optimal results, especially if underlying causes persist.
Is exosome therapy an alternative to hair transplant surgery?
Exosome therapy is a non-surgical option that works with a patient's existing follicles rather than relocating them, which is how hair transplant surgery works. It is generally considered for patients in earlier stages of thinning who still have active follicles, rather than as a direct substitute for transplant surgery in advanced cases. A physician evaluation determines which approach — or combination — fits a patient's specific situation.
StemGrow® Stem Cell Therapy for Hair Loss
Discover how umbilical cord-derived mesenchymal stem cells may help reduce hair loss.
Your case.
In our hands.
Within 48 hours.
A physician on the OmniStem medical team will review your clinical profile and prepare an initial assessment. What follows is a medical conversation.
Your clinical profile 2 MIN
A brief summary of your health context. The medical team uses this to prepare before your first conversation.
Physician review 48 H
Dr. Montoya or a member of the medical team evaluates your profile individually.
A clinical conversation
Your history, your priorities, and what a protocol designed around your clinical profile might include.
No obligation
The case review is informational. The only timeline that matters is yours.
Step 1
A few questions to begin
These help the medical team understand whether OmniStem’s protocols are appropriate for your situation before we speak.
